HOME Study: a Combination Support Package to Increase Uptake of PrEP and HIV/STI Testing

NCT03138135 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 104

Last updated 2021-04-09

No results posted yet for this study

Summary

Home HIV self-testing has been FDA approved and allows users to read their own HIV test results at home, while home sexually transmitted infection (STI) test self-collection allows men to use a swab at home and mail it in for testing. The purpose of this study is to learn how Men who have Sex with Men (MSM) use these new testing options, a set of online support tools, and the option to test with someone to support them (a testing "buddy").

We will also evaluate whether the online tools help these men to connect with HIV prevention services such as Pre-Exposure Prophylaxis (PrEP) if they test HIV negative, and to HIV care services if they test HIV positive.

Conditions

  • HIV Prevention
  • Sexually Transmitted Diseases
  • Pre-Exposure Prophylaxis

Interventions

BEHAVIORAL

HOME Study intervention

Access to home HIV test kits, home STI self-collection kits, the HOME Study website, and the SexPro HIV risk assessment tool.

BEHAVIORAL

Control

Counseling about the importance of quarterly HIV/STI testing and a PrEP information pamphlet.

Sponsors & Collaborators

  • National Institute of Allergy and Infectious Diseases (NIAID)

    collaborator NIH
  • San Francisco Department of Public Health

    collaborator OTHER_GOV
  • University of California, San Francisco

    collaborator OTHER
  • Public Health Foundation Enterprises, Inc.

    lead OTHER

Principal Investigators

  • Hyman Scott, MD, MPH · Public Health Foundation Enterprises; San Francisco Department of Public Health

  • Susan Buchbinder, MD · Public Health Foundation Enterprises; San Francisco Department of Public Health

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-09
Primary Completion
2018-11-30
Completion
2018-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03138135 on ClinicalTrials.gov